Yeah, what Merc said.
Surprisingly, not a lot of people seem to know this, but both Letro and Mase are about even strength-wise, e.g. in their ability to reduce estrogen.
Mase:
And at a percentage highly commensurate to that is Letro’s rapid, dose dependent (to reach optimal prevention) suppression rate…
This also explains why neither is recommended during cycle unless gyno appears and the user prefers not to wait post-cycle (which is acceptable due to rapid response time, and obliteration of symptoms even after elapsed time).
So there you have it.